Log in here
Top Journalists
>
Kristie L. Kahl

Kristie L. Kahl

Vice President of Content at CURE

Contact this person
Email address
k*****@*******.comGet email address
Influence score
51
Phone
(XXX) XXX-XXXXGet mobile number
Location
United States
Languages
  • English
Covering topics
  • Health & Medicine

View more media outlets and journalists by signing up to AI PR

View latest data and reach out all from one place
Sign up to AI PR Toolkit

Recent Articles

curetoday.com

Patients With Resectable NSCLC See Benefits from Pre- and Post ... - Curetoday.com

Neoadjuvant (pre-surgical) treatment with Opdivo (nivolumab) plus chemotherapy followed by surgery and adjuvant (treatment administered following the main treatment) Opdivo significantly improved event-free survival (EFS, the time a patient lives without complications from the disease), compared with placebo plus chemotherapy, in patients with previously untreated resectable (able to be removed via surgery) stage 2 to 3B non-small cell lung cancer (NSCLC), according to data from the phase 3 Ch…
almost 3 years ago
curetoday.com

Keytruda Plus Xtandi Showed No Improvements in Prostate Cancer ... ...

The addition of Keytruda (pembrolizumab) to Xtandi (enzalutamide) showed no improvements in radiographic progression-free survival (rPFS; time from treatment until new cancer lesions are seen on scans) and overall survival (OS; time from treatment until death from any cause), when comparing Xtandi alone in patients with metastatic castration-resistant prostate cancer (mCRPC), according to data from the KEYNOTE-641 study presented at the ESMO Congress 2023. As a result, the primary end points…
almost 3 years ago
curetoday.com

Dato-DXd Betters Progression-Free Survival in Metastatic Breast ......

Patients with hormone receptor-positive HER2-low or HER2-negative metastatic breast cancer tended to have improved progression-free survival (PFS; time from treatment until disease worsening or death) when being treated with datopotamab deruxtecan (Dato-DXd), compared to those being treated with chemotherapy, according to findings from the phase 3 TROPION-Breast-1 clinical trial. The study findings were presented at the 2023 ESMO Congress. “Overall results support Dato-DXd as a potential new…
almost 3 years ago
curetoday.com

Skin Care Essentials To Address Appearance-Related Side Effects ......

In part one of CURE’s “Radiance Unveiled: Skincare and Makeup Strategies Throughout Breast Cancer Treatment” webinar, Rudy Miles, a 10-year Look Good Feel Better volunteer and national trainer, and Olivia Summer Hutcherson, a three-time survivor and thriver, discussed skincare during cancer treatment to assist patients in their daily routine, discussing what products they should use and what to avoid. In this segment, Miles focused on a daily routine patients can follow as part of their s…
almost 3 years ago
curetoday.com

Lip Techniques to Use To Negate Appearance-Related Effects From ......

In part one of CURE’s “Radiance Unveiled: Skincare and Makeup Strategies Throughout Breast Cancer Treatment” webinar, Rudy Miles, a 10-year Look Good Feel Better volunteer and national trainer, and Olivia Summer Hutcherson, a three-time survivor and thriver, offered techniques in applying lip care. “We had a firsthand testimonial that sometimes the appearance, really the side effects of the skin, is dryness. And believe it or not, that also affects the lips,” Miles said. In addition, M…
almost 3 years ago
curetoday.com

Caring for a Wig in Patients With Cancer-Related Hair Loss - Cureto...

In part four of CURE’s “Confidently You: Choosing and Styling Wigs that Look and Feel Right” webinar, Daniela Hernandez-Salas, a Look Good Feel Better volunteer, discussed how to wash and care for a wig worn by patients with cancer experiencing treatment-related hair loss. Summary: 00:04 – Shampooing a wig If a patient wears one wig every day, they should shampoo it every two to three weeks; however, this could be dependent on perspiration and wear. For example, Daniela Hernandez-Salas…
almost 3 years ago
curetoday.com

Tips for Hair Loss and Regrowth During Cancer Treatment - Curetoday...

In part one of CURE’s “Confidently You: Choosing and Styling Wigs that Look and Feel Right” webinar, Daniela Hernandez-Salas, a Look Good Feel Better volunteer, spoke about her journey with hair loss and, based on her experience, offered tips for haircare and hair loss. In particular, she overviewed wigs and head coverings, as well as way to deal with hair loss and regrowth, while also offering things to avoid along the way. Summary: 00:36 – Wigs and head coverings for patients with c…
almost 3 years ago
curetoday.com

How to Wear and Adjust to Wearing a Wig During Cancer Treatment - C...

In part two of CURE’s “Confidently You: Choosing and Styling Wigs that Look and Feel Right” webinar, Daniela Hernandez-Salas, a Look Good Feel Better volunteer, demonstrated how to put on and adjust a wig for patients who are undergoing treatment and experiencing hair loss as a result. “When I first started wearing the wig, this was probably the most difficult for me to get thing to get used to,” Hernandez-Salas explained. She overviewed the proper placement of a wig and how to adjust…
almost 3 years ago
curetoday.com

How to Style a Wig After Hair Loss From Cancer Treatment - Curetoda...

In part three of CURE’s “Confidently You: Choosing and Styling Wigs that Look and Feel Right” webinar, Daniela Hernandez-Salas, a Look Good Feel Better volunteer, offered ways for patients with cancer to style their wigs following hair loss from treatment. “So the wonderful thing about wigs is that you really don’t ever have to style wigs that much,” Hernandez-Salas explained. “wigs have memory. So even after you shampoo them, they come right back to (their original style).” In particu…
almost 3 years ago
curetoday.com

A Look at Novel Immune Therapies for Kidney Cancer - Curetoday.com

While some immunotherapy drugs have been approved for the treatment of renal cell carcinoma (RCC), researchers are still investigating how to best harness the immune system for this patient population, explained Dr. Vivek Narayan. “I think with novel immune therapy development in kidney cancer, it appears that we’re really building on the effective backbone of PD1/CTLA4 inhibition,” Narayan, assistant professor of medicine (hematology-oncology) at the Hospital of the University of Pennsylvani…
almost 3 years ago
curetoday.com

Chemo Plus Tecentriq Shows Improvements in Endometrial ... - Cureto...

The treatment combination of Tecentriq (atezolizumab) and platinum-based chemotherapy demonstrated benefits for patients with frontline advanced or recurrent endometrial carcinoma, specifically patients with deficient mismatch repair (dMMR) status, according to data from a phase 3 trial presented at the ESMO Congress 2023. As defined by National Cancer Institute, dMMR describes cells that mutate and could lead to cancer, which is common among patients with endometrial cancer. The randomized,…
almost 3 years ago